跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule
Approved
STANDARD
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a0413b3e3675e70b
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
a0413b3e3675e70b
Product Name
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule
Artg Id
168803
Artg Name
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2012-02-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/dd9fae877337c2bc7bbb5fa1556fdbf0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/06ee7657fd3b4e62eb7aa1199733477d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a0413b3e3675e70b
Type
Standard
Back to TGA Approvals